Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers
about
sameAs
Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban--an oral, direct factor Xa inhibitor--are not affected by aspirinNovel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.Clinical efficacy and safety of fondaparinux in the prevention and treatment of venous and arterial thrombosis.Fondaparinux: an overview.
P2860
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Absence of interaction of fond ...... cam in healthy male volunteers
@ast
Absence of interaction of fond ...... cam in healthy male volunteers
@en
Absence of interaction of fond ...... cam in healthy male volunteers
@nl
type
label
Absence of interaction of fond ...... cam in healthy male volunteers
@ast
Absence of interaction of fond ...... cam in healthy male volunteers
@en
Absence of interaction of fond ...... cam in healthy male volunteers
@nl
prefLabel
Absence of interaction of fond ...... cam in healthy male volunteers
@ast
Absence of interaction of fond ...... cam in healthy male volunteers
@en
Absence of interaction of fond ...... cam in healthy male volunteers
@nl
P2093
P1476
Absence of interaction of fond ...... cam in healthy male volunteers
@en
P2093
Adam F Cohen
Alix Santoni
Céline Ollier
Jacobus Burggraaf
Paul M M van Haard
Richard A Faaij
Rik C Schoemaker
Rik de Greef
Thierry Duvauchelle
P356
10.2165/00003088-200241002-00005
P407
P478
41 Suppl 2
P577
2002-01-01T00:00:00Z
P6179
1012546011